Target identification in chemical genetics: The (often) missing link

Chemistry and Biology

Volumn 11, Issue 5, 2004, Pages 593-597

  Burdine, Lyle ^a   Kodadek, Thomas ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DRUG RECEPTOR; PEPTIDE; TRAPOXIN A;

AFFINITY CHROMATOGRAPHY; CHEMISTRY; COMBINATORIAL CHEMISTRY; GENETIC PROCEDURES; HUMAN; METABOLISM; METHODOLOGY; REVIEW;

BIOSENSING TECHNIQUES; CHROMATOGRAPHY, AFFINITY; COMBINATORIAL CHEMISTRY TECHNIQUES; DNA; GENETIC TECHNIQUES; HUMANS; PEPTIDES; RECEPTORS, DRUG;

EID: 2642553258     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2004.05.001     Document Type: Review

References (28)

1. Schreiber S.L. Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg. Med. Chem. 6:1998;1127-1152
2. Schreiber S.L. The small molecule approach to biology. Chem. & Eng. 1199 News. 81:2003;51-61
3. Crews C.M., Splittgerber U. Chemical genetics. exploring and controlling cellular processes with chemical probes Trends Biochem. Sci. 24:1999;317-320
4. Clemons P.A., Koehler A.N., Wagner B.K., Sprinings T.G., Spring D.R., King R.W., Schreiber S.L., Foley M.A. A one-bead, one-stock solution approach to chemical genetics. part 2 Chem. Biol. 8:2001;1183-1195
5. Stockwell B.R., Haggarty S.J., Schreiber S.L. High-throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. Chem. Biol. 6:1999;71-83
6. Taunton J., Hassig C.A., Schreiber S.L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science. 272:1996;408-411
7. Taunton J., Collins J.L., Schreiber S.L. Synthesis of natural and modified trapoxens, useful reagents for exploring histone deacetylase function. J. Am. Chem. Soc. 118:1996;10412-10422
8. Ding S., Wu T.Y.H., Brinker A., Peters E.C., Hur W., Gray N.S., Schultz P.G. Synthetic small molecules that control stem cell fate. Proc. Natl. Acad. Sci. USA. 100:2003;856-861
9. Doble B.W., Woodgett J.R. GSK-3. tricks of the trade for a multi-tasking kinase J. Cell Sci. 116:2003;1175-1186
10. Harding M.W., Galat A., Uehling D.E., Schreiber S.L. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 341:1989;758-760
11. Schreiber S.L., Crabtree G.R. The mechanism of action of cyclosporin A and FK506. Immunol. Today. 13:1992;136-142
12. Kodadek T. Protein-detecting microarrays. Trends Biochem. Sci. 27:2002;295-300
13. Shuker S.B., Hajduk P.J., Meadows R.P., Fesik S.W. Discovering high-affinity ligands for proteins. SAR by NMR Science. 274:1996;1531-1534
14. Maly D.J., Choong I.C., Ellman J.A. Combinatorial target-guided ligand assembly. identification of potent subtype-selective c-Src inhibitors Proc. Natl. Acad. Sci. USA. 97:2000;2419-2424
15. Sem D.S., Bertolaet B.L., Baker B., Chang E., Costache A.D., Coutts S., Dong Q., Hansen M., Hong V., Huang X., et al. Systems-based design of bi-ligand inhibitors of oxidoreductases. Filling the chemical proteomic toolbox Chem. Biol. 11:2004;185-194
16. Profit A.A., Lee T.R., Lawrence D.S. Bivalent inhibitors of protein tyrosine kinases. J. Am. Chem. Soc. 121:1999;280-283
17. Green N.S., Palaninathan S.K., Sacchettini J.C., Kelly J.W. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization. J. Am. Chem. Soc. 125:2003;13404-13414
18. Kitov P.I., Shimizu H., Homans S.W., Bundle D.R. Optimization of tether length in nonglycosidically linked bivalent ligands that target sites 2 and 1 of a Shiga-like toxin. J. Am. Chem. Soc. 125:2003;3284-3294
19. Morken J.P., Kapoor T.M., Feng S., Shirai F., Schreiber S.L. Exploring the leucine-proline binding pocket of the Src SH3 domain using structure-based, split pool synthesis and affinity-based selection. J. Am. Chem. Soc. 120:1998;30-36
20. Alluri P.G., Reddy M.M., Bacchawat-Sikder K., Olivos H.J., Kodadek T. Isolation of protein ligands from large peptoid libraries. J. Am. Chem. Soc. 125:2003;13995-14004
21. Ong S.E., Foster L.J., Mann M. Mass spectrometric-based approaches in quantitative proteomics. Methods. 29:2003;124-130
22. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17:1999;994-999
23. Jaeger S., Eriani G., Martin F. Results and prospects of the yeast three-hybrid system. FEBS Lett. 556:2004;7-12
24. Pek Y.L., Armour C.D., Stepaniants S.B., Cavet G., Wolf M.K., Butler J.S., Hinshaw J.C., Garnier P., Prestwich G.D., Leonardson A., et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell. 116:2004;121-137
25. Giaever G., Flaherty P., Kumm J., Proctor M., Nislow C., Jaramillo D.F., Chu A.M., Jordan M.I., Arkin A.P., Davis R.W. Chemogenomic profiling. Identifying the functional interactions of small molecules in yeast Proc. Natl. Acad. Sci. USA. 101:2004;793-798
26. Blagoev B., Kratchmarova I., Ong S.E., Nielsen M., Foster L.J., Mann M. A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat. Biotechnol. 21:2003;315-318
27. Ranish J.A., Yi E.C., Leslie D.M., Purvine S.O., Goodlett D.R., Eng J., Aebersold R. The study of macromolecular complexes by quantitative proteomics. Nat. Genet. 33:2003;349-355
28. Oda Y., Owa T., Sato T., Boucher B., Daniels S., Yamanaka H., Shinohara Y., Yokoi A., Kuromitsu J., Nagasu T. Quantitative chemical proteomics for identifying candidate drug targets. Anal. Chem. 75:2003;2159-2165